3 TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2025 WOMEN IN SCIENCE 52 Paving the way for success ONESOURCE 54 Discussing drug-device combinations with Onesource’s Neeraj Sharma CPHI REPORT 56 CPHI Annual Report re-analysed: All bets off in Trump’s final term? Not for me BCG-IPSO REPORT 62 India’s CRDMO sector growth potential at $22 - $25 Billion by 2035, driving global pharma innovation CONTENTS CHIARA BAROZZI Analytical Validation & Services Manager Cerbios-Pharma SA 50 WOMEN IN SCIENCE ROSA MARIA MORENO Chief Operations Officer JOAN FEIXAS Chief Executive Officer LAURA GRAU Chief Commercial Officer Enantia 48 INTERVIEW from page 65
RkJQdWJsaXNoZXIy MjY2OTA4MA==